Clinical Research Repository Disburser
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Disburser
Login

Repository: Prostate SPORE

General

The SPORE repository has more than 50,000 specimen aliquots from more than 4,500 consented patients with prostate cancer treated at Northwestern Memorial Hospital and NorthShore University Health System. In addition to frozen tissue on nearly 3,500 patients, the repository has blood (serum, plasma, peripheral blood mononuclear cells, and blood spots) and urine samples. Sample accrual has been expanded to include not only patients undergoing surgery, but also non-surgical patients with advanced disease who are undergoing radiotherapy or chemotherapy, thus spanning the spectrum of disease. Corresponding formalin-fixed paraffin-embedded (FFPE) tissue is available on each prostatectomy case, and biopsies are available in most cases as well. More than 50 tissue microarrays have been generated and are available to interested investigators for research studies. Detailed clinical and pathologic data associated with each specimen is uploaded by data coordinators into the SPORE database sample management systems with appropriate protection of patient confidentiality.

  • IRB Process: IRB approval or exemption must be obtained prior to release of data or specimens. The request form will ask you input your IRB number or declare your IRB exemption.
  • Scientific Justification: The request form will ask you to attach a 'Methods/Justifications' document that should contain a scientific explanation jutifying the disburment of the clincial data and/or clinical speicmens.
  • Questions:
    • For all other questions about the specimen request process, please contact:
    • To discuss your specimen needs, please contact a SPORE Biospecimen director:
Specimen

Summarize available information for prostate cancer patients at Northwestern Memorial Hospital.

Patient Characteristics

NU Prostate Cancer Patients Who Underwent Surgery

 

Overall, N = 3,747

Patients with ≥ 1 Tissue Specimen, N = 3,092

Patients with ≥ 1 Non-Tissue Specimen, N = 3,273

Gleason, N (%)

 

 

 

Grade Group 1 (≤ 6)

1,337 (36%)

1,083 (35%)

1,152 (35%)

Grade Group 2 (3+4)

1,365 (36%)

1,139 (37%)

1,200 (37%)

Grade Group 3 (4+3)

631 (17%)

528 (17%)

563 (17%)

Grade Group 4 (8)

119 (3.2%)

106 (3.4%)

103 (3.1%)

Grade Group 5 (9 or 10)

284 (7.6%)

231 (7.5%)

247 (7.5%)

Missing

11 (0.3%)

5 (0.2%)

8 (0.2%)

PSA Follow-up

 

 

 

Has PSA Follow-up, N (%)1

3,422 (91%)

2,823 (91%)

2,991 (91%)

Time to Last PSA Follow-up (Months), Median (IQR)2

83 (44, 137)

83 (44, 137)

82 (44, 133)

Vital Status, N (%)

 

 

 

Alive

3,438 (92%)

2,843 (92%)

3,016 (92%)

Dead

305 (8.1%)

247 (8.0%)

253 (7.7%)

Missing

4 (0.1%)

2 (<0.1%)

4 (0.1%)

Follow-up

 

 

 

Time to Last Follow-Up (Months), Median (IQR)23

140 (92, 179)

141 (92, 180)

136 (92, 174)

Disease Status, N (%)

 

 

 

Has PSA Recurrence4

1,107 (30%)

906 (29%)

969 (30%)

Has Distant Metastasis5

110 (2.9%)

86 (2.8%)

86 (2.6%)

1PSA follow-up defined as PSA lab at least 6 months post-surgery.

2Time measured in months from date of surgery.

3Follow-up calculated among alive patients.

4PSA recurrence defined as PSA lab > 0.01 ng/mL at least 6 weeks post-surgery and confirmatory PSA lab > 0.01 ng/mL 2 weeks later.

5Has distant metastasis date in REDCap recurrence instrument.

Specimen Availability

Available Specimens for NU Prostate Cancer Patients Who Underwent Surgery

 

N = 3,747

Specimen Type, N (%)

 

FFPE Block1

685 (18%)

Frozen Tissue

2,890 (77%)

PBMC

2,129 (57%)

Plasma

2,809 (75%)

Prostatic Fluid

1,521 (41%)

Seminal Vesical Fluid

646 (17%)

Serum

2,834 (76%)

Urine

422 (11%)

Whole Blood

1,376 (37%)

1FFPE blocks may be available on all consented patients through NM Pathology.

Available Aliquots for NU Prostate Cancer Patients Who Underwent Surgery

 

N = 59,890

Aliquot Type, N

 

FFPE Block1

11,421

Frozen Tissue

10,989

PBMC

3,945

Plasma

8,780

Prostatic Fluid

1,534

Seminal Vesical Fluid

650

Serum

6,473

Urine

1,650

Whole Blood

2,018

1FFPE blocks may be available on all consented patients through NM Pathology.

Data